Avinger, Inc. Stock

Equities

AVGR

US0537348775

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:30:00 2024-04-26 pm EDT 5-day change 1st Jan Change
3.73 USD -5.08% Intraday chart for Avinger, Inc. -5.09% +37.64%
Sales 2024 * 10.5M Sales 2025 * 13.93M Capitalization 5.92M
Net income 2024 * -16M Net income 2025 * -14M EV / Sales 2024 * 0.56 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.42 x
P/E ratio 2024 *
-1.79 x
P/E ratio 2025 *
-2.76 x
Employees 70
Yield 2024 *
-
Yield 2025 *
-
Free-Float 84.15%
More Fundamentals * Assessed data
Dynamic Chart
1 day-5.08%
1 week-5.09%
Current month+20.36%
1 month+26.66%
3 months+29.97%
6 months-0.53%
Current year+37.64%
More quotes
1 week
3.54
Extreme 3.54
4.01
1 month
2.92
Extreme 2.9239
4.37
Current year
2.50
Extreme 2.5
5.45
1 year
2.50
Extreme 2.5
18.00
3 years
2.50
Extreme 2.5
438.00
5 years
2.50
Extreme 2.5
2 340.00
10 years
2.50
Extreme 2.5
1 000 000.00
More quotes
Managers TitleAgeSince
Founder 63 07-03-07
Chief Executive Officer 61 14-12-28
Director of Finance/CFO 41 19-12-31
Members of the board TitleAgeSince
Chief Executive Officer 61 14-12-28
Chairman 81 14-11-30
Director/Board Member 72 11-02-28
More insiders
Date Price Change Volume
24-04-26 3.73 -5.08% 6,045
24-04-25 3.93 +6.21% 12,434
24-04-24 3.7 +0.27% 2,902
24-04-23 3.69 -2.51% 3,256
24-04-22 3.785 -3.69% 12,010

Delayed Quote Nasdaq, April 26, 2024 at 04:30 pm EDT

More quotes
Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. It has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
3.73 USD
Average target price
5 USD
Spread / Average Target
+34.04%
Consensus